CTI Biopharma | CTIC - Action



Action Changement Date
Baxter International USD 2.23B 228M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Geron USD 116.64M 21.21M 2025-12
Incyte USD 101.06M 17.61M 2025-12
Novartis USD 6.42B 114M 2025-09
Novartis USD 6.42B 114M 2025-09